Cancers Webinar | Plasma Oncology
Welcome from the Chairs
8th Cancers Webinar
Plasma Oncology
Cold atmospheric plasma (CAP), also called non-thermal plasma (NTP), is a partially ionized gas that is being studied as a localized cancer therapy, in a field now coined as ‘plasma oncology’. CAP is created by applying electricity to a gas at atmospheric pressure and near room temperature and consists of neutral gas molecules, radicals, and excited species, which can rapidly react with cancerous tissue and induce therapeutic effects. These include the modulation and activation of multiple signaling pathways in cancer cells and the stimulation of host, anti-cancer immunity. Over the past decade, there is mounting evidence of the therapeutic, anti-cancer potential of CAP based on preclinical investigations: 2D and 3D in vitro studies, in silico computer modeling, and in vivo models. Now, the major challenge for the plasma oncology field is to take fundamental insights and translate this technology for clinical applications.
For this webinar, we have invited experts in the field of plasma oncology to present the state-of-the-art findings and provide insights into the next steps towards clinical translation.
Date: 24 October 2022
Time: 3:00pm CEST | 9:00am EDT | 9:00pm CST Asia
Webinar ID: 876 2112 5690
Webinar Secretariat: cancers.webinar@mdpi.com
Chairs
Research Group PLASMANT, Department of Chemistry, University of Antwerp, Wilrijk-Antwerp, Belgium
Prof. Dr. Annemie Bogaerts is Collection Editor of Topical Collection "Plasma Oncology". Her research interests: plasma; plasma chemistry; plasma oncology; plasma medicine; plasma catalysis; computer modeling; plasma cancer immunotherapy
Research Group PLASMANT, Department of Chemistry, and Center for Oncological Research (CORE), University of Antwerp, Wilrijk-Antwerp, Belgium
Dr. Angela Privat-Maldonado is Collection Editor of Topical Collection "Plasma Oncology" with research interests: plasma oncology; plasma medicine; 3-dimensional in vitro cancer models; cell biology, oxidative stress, tumor microenvironment
Research Group PLASMANT, Department of Chemistry, and Center for Oncological Research (CORE), University of Antwerp, Wilrijk-Antwerp, Belgium
Dr. Abraham Lin is Collection Editor of Topical Collection "Plasma Oncology" with research interests: plasma medicine; plasma device development; combination cancer therapy; immune modulation; tumor microenvironment; plasma dosimetry
Invited Speakers
Department of Microbiology and Immunology, Institute of Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, PA, USA
Dr. Vandana Miller, MD is an Associate Professor in the Department of Microbiology & Immunology and the focus of her research is the in vitro and in vivo immunomodulatory effects of non-thermal plasma for applications in immunotherapy of cancer, viral diseases, and wound healing. Her training in clinical medicine as well as fundamental sciences, especially microbiology and immunology, has prepared her well for this new field of research. She has been a co-investigator on several grants and co-authored more than 50 papers and two book chapters pertaining to plasma medical applications since 2013. She collaborates with clinicians, plasma chemists, and engineers internationally in the study of the fundamental understanding of plasma components important for biological effects, including device development and clinical trials.
Institut du Cancer de Montréal (ICM), Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, QC, Canada
Dr. Audrey Glory’s background includes biochemistry and immunology (M.Sc. in Infectiology and Immunology, Ph.D. in Biochemistry), with an emphasis on novel cancer treatments. During her PhD, she studied the molecular mechanisms of hyperthermia and thermotolerance in cervical cancer cells. She is currently working as a postdoctoral fellow in Dr. Philip Wong's lab, studying the use non-thermal plasma for breast cancer treatment. Next year, their team will lead the first phase I clinical study on the use of non-thermal plasma on breast cancer patients.
ZIK Plasmatis, Leibniz Institute for Plasma Science and Technology (INP), Greifswald, Germany
Dr. Sander Bekeschus is a human biologist by training with a Ph.D. in immunology. In 2016, he established the independent and third-party-funded research group “Plasma-Redox-Effects” at the Leibniz Institute for Plasma Science and Technology (INP), which became a permanent research group under his leadership in 2021. His interests are therapeutic applications of reactive oxygen and nitrogen species generated by gas plasma technology in dermatology, oncology, and immunology in the context of redox biology and medicine. Awarded with the Early Career Award of the International Society for Plasma Medicine (ISPM) and the Young Investigator Award of the Society for Free Radical Biology and Medicine International (SFRR-I), he has authored and co-authored over 150 publications and 15 book chapters on gas plasma technology for biomedical applications.
Webinar Content
Program
|
Speaker/Presentation |
Time in CEST |
Time in EDT |
|
Prof. Dr. Annemie Bogaerts Chair Introduction |
3:00 - 3:10 pm |
9:00 - 9:10 am |
|
Dr. Vandana Miller Clinical Considerations for Plasma Therapy for Cancer |
3:10 - 3:40 pm |
9:10 - 9:40 am |
|
Q&A |
3:40 - 3:45 pm |
9:40 - 9:45 am |
|
Dr. Audrey Glory Phase I Clinical Study with Plasma Therapy |
3:45 - 4:15 pm |
9:45 - 10:15 am |
|
Q&A |
4:15 - 4:20 pm |
10:15 - 10:20 am |
|
Dr. Sander Bekeschus Cell Death Signaling and Immune Responses with Anti-cancer Cold Physical Plasma Therapy |
4:20 - 4:50 pm |
10:20 - 10:50 am |
|
Q&A |
4:50 - 4:55 pm |
10:50 - 10:55 am |
|
Prof. Dr. Annemie Bogaerts Closing of Webinar |
4.55 - 5:00 pm |
10:55 - 11:00 am |
Relevant SI
A topical collection in Cancers (ISSN 2072-6694). This collection belongs to the section "Cancer Therapy".
Collection Editors: Prof. Dr. Annemie Bogaerts, Dr. Angela Privat-Maldonado & Dr. Abraham Lin
Sponsors and Partners
Organizers
